PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 158 filers reported holding PDL BIOPHARMA INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $868,000 | -12.4% | 267,384 | -41.7% | 0.02% | 0.0% |
| Q3 2019 | $991,000 | -53.8% | 458,983 | -32.9% | 0.02% | -47.8% |
| Q2 2019 | $2,147,000 | -45.9% | 683,610 | -36.0% | 0.05% | -47.1% |
| Q1 2019 | $3,972,000 | +3719.2% | 1,067,678 | +2922.4% | 0.09% | +4250.0% |
| Q1 2018 | $104,000 | +103.9% | 35,326 | +98.4% | 0.00% | +100.0% |
| Q4 2017 | $51,000 | -85.8% | 17,804 | -83.2% | 0.00% | -85.7% |
| Q3 2017 | $359,000 | – | 106,046 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Argent Trust Co | 41,405 | $102,270 | 0.01% |
| Diversified Trust Co | 11,029 | $26,469 | 0.00% |
| RHUMBLINE ADVISERS | 612 | $1,511 | 0.00% |
| Ancora Advisors LLC | 4,948 | $0 | 0.00% |
| Westside Investment Management, Inc. | 500 | $0 | 0.00% |
| HANCOCK WHITNEY CORP | 128,396 | $0 | 0.00% |